Indefinite Delivery Contract 36C26324D0042

Award Date 2/7/24
Last Date to Order 9/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide 503B compounding pharmaceuticals. The IDC has a ceiling value of $441,181 and a performance period through September 2025, with no set-aside designation. As part of this IDC, the VA has issued two delivery orders to Wells Pharma: a $220,590.50 order in February 2024 and a $97,340.50...
This single-award indefinite delivery contract was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $7.27 million contract, with a performance period ending September 29, 2029, is for the provision of metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an...
The key products and services being delivered under this federal contract IDV award are specialized pharmacy services and hazardous compounding for chemotherapy and other intravenous medications to support the Department of Veterans Affairs (VA) healthcare system. The prime contractor, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, has been awarded a single-award Indefinite Delivery Contract (IDC) worth $6.75 million by...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The contract has a ceiling value of $10,000,000 and a period of performance through October 31, 2025. Under this IDC, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) will provide highly specialized pharmaceutical...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Aphena Pharma Solutions-Tennessee, LLC, a subsidiary of Aphena Pharma Solutions Holdings, Inc., for pharmaceutical repackaging, distribution, and inventory management services. The $383,458,720.32 IDC was awarded by the VA's Veterans Integrated Service Network (VISN) 15 and runs from November 1, 2019 to October 31, 2024, enabling the VA to efficiently procure these critical services across its nationwide...
The Department of Veterans Affairs Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Palisade Strategies LLC, a Service-Disabled Veteran-Owned Small Business, to provide pharmacy benefit management services. The $1,000,000 single-award IDC has an ultimate completion date of December 31, 2024. Under this contract, Palisade Strategies LLC has been issued a series of fixed-price delivery orders to deliver pharmacy benefit management, pharmacy refill, emergency...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC), valued up to $1,772,128.68, to Palisade Strategies, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB). The contract is for the delivery of "VA VHA FIRST FILL / URGENT PRESCRIPTION FULFILLMENT" services to the VA's Veterans Integrated Service Network (VISN) 10 region, which covers Ohio, Michigan, and Indiana. This single-award IDC has an ultimate completion date of March 31, 2026 and...
This Federal Supply Schedule contract awards Pacira Pharmaceuticals, Inc. as the prime contractor to provide the Department of Veterans Affairs (VA) with a range of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contract has a total potential value of $93,582,250 over the 5-year period of performance from September 2022 to August 2027. As the prime, Pacira Pharmaceuticals will deliver the contracted...
The federal contract IDV award is for Chemo Compounding Services provided by Optum Pharmacy 801, Inc. (dba Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. As the prime contractor, Avella will be responsible for compounding customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) healthcare...
  • 36C26324D0042
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a single-award Indefinite Delivery Contract (IDC) to Pine Pharmaceuticals LLC, an FDA-registered 503B outsourcing facility, to provide 503B compounding pharmaceutical products and services. The $136,800 IDC has an ultimate completion date of September 30, 2025.

Under this IDC, the VA VHA has issued two firm-fixed price delivery orders totaling $136,800. The first order, valued at $68,400, was awarded on February 7, 2024 with a completion date of September 30, 2024. The second order, also valued at $68,400, was awarded on October 1, 2024 with a completion date of September 30, 2025. All work will be performed at Pine Pharmaceuticals' facility in Tonawanda, New York. This contract award expands Pine Pharmaceuticals' federal customer base beyond its prior work with the Department of Health and Human Services, demonstrating the company's capability to provide specialized pharmaceutical services to support various healthcare programs across the federal government.

Generated 1/29/25, 9:10 AM